SOME PHARMACOLOGICAL PROPERTIES OF A NEW ADRENERGIC NEURONE-BLOCKING AGENT, N-(BETA-GUANIDINOETHYL)-HEXAHYDROBENZO-(D)-AZOCINE SULPHATE (PH 881-7).
D018663:Adrenergic Agents; D001341:Autonomic Nervous System; D001392:Azocines; D001794:Blood Pressure; D001795:Blood Pressure Determination; D002415:Cats; D003913:Dextroamphetamine; D006145:Guanethidine; D006584:Hexamethonium Compounds; D007022:Hypotension; D051379:Mice; D010600:Pharmacology; D051381:Rats; D012106:Research; D013431:Sulfates; D013565:Sympatholytics; D014116:Toxicology
D018663:Adrenergic Agents; D001392:Azocines; D006584:Hexamethonium Compounds; D013431:Sulfates; D013565:Sympatholytics; D003913:Dextroamphetamine; D006145:Guanethidine
AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CATS; DEXTRO AMPHETAMINE; EXPERIMENTAL LAB STUDY; GUANETHIDINE; HEXAMETHONIUM COMPOUNDS; HYPOTENSION; MICE; PHARMACOLOGY; RATS; SYMPATHOLYTICS; TOXICOLOGIC REPORT